Abstract:Object: Delayed cerebral vasospasm after subarachnoid hemorrhage (SAH) may be evoked by the decreased availability of nitric oxide (NO). Increased cerebrospinal fluid (CSF) levels of asymmetric dimethyl-L-arginine (ADMA), an endogenous inhibitor of NO synthase (NOS), have been associated with the course and degree of cerebral vasospasm in a primate model of SAH. In this study, the authors sought to determine if similar changes in CSF ADMA levels are observed in patients with SAH, and whether these changes are associated with NO and NOS metabolite levels in the CSF and the presence of cerebral vasospasm. Methods: Asymmetric dimethyl-L-arginine, L-arginine, L-citrulline, and nitrite levels were measured in CSF and serum samples collected during the 21-day period after a single aneurysmal SAH in 18 consecutive patients. Samples were also obtained in a control group consisting of seven patients with Chiari malformation Type I and five patients with spontaneous intracerebral hemorrhage without SAH. Vasospasm, defined as a greater than 11% reduction in the anterior circulation vessel diameter ratio compared with the ratio calculated from the initial arteriogram, was assessed on cerebral arteriography performed around Day 7. Results: In 13 patients with SAH, arteriographic cerebral vasospasm developed. Cerebrospinal fluid ADMA levels in patients with SAH were higher than in those in the control group (p < 0.001). The CSF ADMA level remained unchanged in the five patients with SAH without vasospasm, but was significantly increased in patients with vasospasm after Day 3 (6.2 +/- 1.7 microM) peaking during Days 7 through 9 (13.3 +/- 6.7 microM; p < 0.001) and then gradually decreasing between Days 12 and 21 (8.8 +/- 3.2 microM; p < 0.05). Nitrite levels in the CSF were lower in patients with vasospasm compared to patients without vasospasm (p < 0.03). Cerebrospinal fluid ADMA levels positively correlated with the degree of vasospasm (correlation coefficient [CC] = 0.88, p = 0.0001; 95% confidence interval [CI] 0.74-0.95) and negatively correlated with CSF nitrite levels (CC = -0.55; p = 0.017; 95% CI -0.81 to -0.12). Conclusions: These results support the hypothesis that ADMA is involved in the progression of cerebral vasospasm. Asymmetric dimethyl-L-arginine and its metabolizing enzymes may be a future target for treatment of cerebral vasospasm after SAH.

Nitric Oxide Concentration in Cerebrospinal Fluid of Patients with Aneurysmal Subarachnoid Hemorrhage

Changes of Endothelin, Nitric Oxide and Nitricoxid Synthase Levele in Cerebrospinal Fluid and Blood in Patients with Aneurysmal Subarachnoid Hemorrhage

Alterations of Nitric Oxide Concentration in the Cerebrospinal Fluid of Patients with Subarachnoid Hemorrhage During Continuous Lumbar Drainage

Association of an endogenous inhibitor of nitric oxide synthase with cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage

Relation of cerebral energy metabolism and extracellular nitrite and nitrate concentrations in patients after aneurysmal subarachnoid hemorrhage

[Symptomatic Vasospasm after Subarachnoid Hemorrhage: Study of 186 Cases].

Measurement of nitric oxide and brain tissue oxygen tension in patients after severe subarachnoid hemorrhage

Upregulation of Connexin 40 Mediated by Nitric Oxide Attenuates Cerebral Vasospasm after Subarachnoid Hemorrhage Via the Nitric Oxide-Cyclic Guanosine Monophosphate-Protein Kinase G Pathway.

Effect of the drainage of cerebrospinal fluid in patients with aneurismal subarachnoid hemorrhage: A meta-analysis

Role of Inducible Nitric Oxide Synthase in Chronic Cerebral Vasospasm

Biological defence mechanism in the pathogenesis of prolonged cerebral vasospasm in the patients with ruptured intracranial aneurysms

Feasibility study on the curative effect of the cerebrospinal fluid purification system in treatment pa tients with aneurgsmal spontaneous subarachnoid hemorrhage

Changes in the expression of vasoconstrictors in cerebrospinal fluid from patients with subarachnoid hemorrhage

Trial of the cerebral perfusion response to sodium nitrite infusion in patients with acute subarachnoid haemorrhage using arterial spin labelling MRI

Curative Effectiveness of Nimodipine Perfusion at the Cistern in the Treatment of Cerebral Vasospasm after Aneurysmal Subarachnoid Hemorrhage

Cerebrovascular hemodynanuc changes of cerebral vasospasm after aneurysmal subarachnoid hemorrhage

Association between pro-inflammatory cytokines in cerebrospinal fluid and headache in patients with aneurysmal subarachnoid hemorrhage

The content of plasma catecholamine in aneurysmal subarachnoid hemorrhage and the association with neurogenic pulmonary edema

The relationship between Symptomatic Cerebral vasospasm and high coagulation state following aneurysmal SAH and its prophylactic study

Endothelin and Nitric Oxide Concentration in Patients with Severe Head Injury

Effect of L-arginine on Nitric Oxide and Brain Edema after Subarachnoid Hemorrhage in Rats